Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 3,750 shares at $40.00 ($150K) on 2019-10-28, disclosed to the SEC on 2019-10-30.
Open-market sale of $150k DCPH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |